Susceptibility of Human Herpesvirus 6 to Antivirals In Vitro
- 1 September 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 162 (3) , 634-637
- https://doi.org/10.1093/infdis/162.3.634
Abstract
Human herpesvirus 6 (HHV-6) is a recently recognized human herpesvirus isolated from lymphoid cells and thought to be the causative agent for exanthem subitum. Using dot blot hybridization, the HHV-6 sensitivity pattern to several antivirals was compared with those of herpes simplex virus type 1 and human cytomegalovirus. HHV-6 most closely resembled cytomegalovirus in that it was relatively resistant to the antiviral effects of acyclovir and bromovinyl-deoxyuridine but sensitive to ganciclovir and phosphonoacetic acid. From these results, it appears more likely that HHV-6 infections would respond to ganciclovir and foscarnet than to acyclovir should treatment deemed be advisable, although the low toxicity of acyclovir may allow for its use at doses that might affect replication of HHV-6.Keywords
This publication has 9 references indexed in Scilit:
- Human herpesvirus 6 is closely related to human cytomegalovirusJournal of Virology, 1990
- Human Herpesvirus-6 Infection (Exanthem Subitum) Without RashPediatrics, 1989
- Identification and some properties of a unique DNA polymerase from cells infected with human B-lymphotropic virusJournal of Virology, 1989
- Molecular cloning and mapping of rat cytomegalovirus DNAVirology, 1988
- IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUMPublished by Elsevier ,1988
- A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate.Proceedings of the National Academy of Sciences, 1986
- Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative DisordersScience, 1986
- Genomic Analysis of the Human B-Lymphotropic Virus (HBLV)Science, 1986
- On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine.Proceedings of the National Academy of Sciences, 1981